Kip 25

Oakmark International Disappoints Us

When this fund is good, it shines relative to peers, but when it is bad, it fares far worse.

Dumping a fund when it is down defies a basic investing rule: Buy low and sell high. It’s one reason we’ve stuck by Oakmark International (OAKIX), despite a turbulent run recently. When this fund is good, it is awesome relative to peers, but when it is bad, it fares far worse.

In 2012, 2013, 2016 and 2017, Oakmark International delivered returns that ranked among the top 9% of its peers (funds that invest in a mix of bargain-priced and fast-growing foreign stocks in developed countries). But those outstanding years failed to offset the bad years. In 2018, the fund lost 23%, lagging its peers by nearly nine percentage points.

Things got measurably worse for the fund in 2020. All told, between February 2018 and March 2020, the fund lost 45%. That lags both its peers and the MSCI EAFE index, which tracks foreign stocks in developed countries, by more than 20 percentage points.

To be fair, value-oriented foreign stocks, this fund’s focus, have lagged growth-oriented shares. The performance gap is expansive. Over the past five years, the MSCI EAFE Growth index, which tracks foreign stocks with the fastest growing earnings in foreign developed countries, has returned 5.9% annualized. The MSCI EAFE Value index has sunk 0.8% on average per year. “Today, our portfolios trade at near all-time discounts to their historical averages,” lead manager David Herro wrote in a semi­annual report, “trading at around 40 cents on the dollar.” Two holdings, BNP Paribas and Credit Suisse Group, traded at discounts last seen during the 2007–08 financial crisis, despite stronger balance sheets.

For now, we’re putting Oakmark International on watch as we consider other foreign value funds for the Kiplinger 25. That said, we’re still confident that value investing will come back and, eventually, Oakmark International will, too.

Finding a worthy replacement will be tough. Herro is a hard act to follow. During his 28-year tenure, he was named Morningstar’s international fund manager of the year in 2006 and 2016. In 2010, he was Morningstar’s international stock fund manager of the decade. Herro now runs the fund with Michael Manelli.

Most Popular

Your Guide to Roth Conversions
Special Report
Tax Breaks

Your Guide to Roth Conversions

A Kiplinger Special Report
February 25, 2021
The Berkshire Hathaway Portfolio: All 41 Warren Buffett Stocks Ranked
stocks

The Berkshire Hathaway Portfolio: All 41 Warren Buffett Stocks Ranked

The Berkshire Hathaway portfolio is a diverse set of blue chips, and increasingly, lesser-known growth bets. Here's a look at every stock picked by Wa…
November 16, 2021
Should You Take an Extra Big RMD This Year?
required minimum distributions (RMDs)

Should You Take an Extra Big RMD This Year?

Sometimes only taking the minimum IRA distribution can be a costly mistake. When deciding how much to withdraw this year, you need to consider the big…
November 23, 2021

Recommended

Stock Market Today (12/3/21): Stocks Turn Tail Amid November Jobs Miss, Omicron
Stock Market Today

Stock Market Today (12/3/21): Stocks Turn Tail Amid November Jobs Miss, Omicron

Wall Street capped off an omicron-inspired zigzag week of trading with a dip after November's headline jobs figure came up short.
December 3, 2021
Kiplinger's Weekly Earnings Calendar
stocks

Kiplinger's Weekly Earnings Calendar

Check out our earnings calendar for the upcoming week, as well as our previews of the more noteworthy reports.
December 3, 2021
Stock Market Today (12/2/21): Dow Leads Broad-Market Rally as Boeing Soars
Stock Market Today

Stock Market Today (12/2/21): Dow Leads Broad-Market Rally as Boeing Soars

Boeing was the best blue chip today after Chinese regulators cleared the 737 Max for flight.
December 2, 2021
Stock Market Today (12/1/21): Stocks' Gains Erased as Omicron Reveals Itself in U.S.
Stock Market Today

Stock Market Today (12/1/21): Stocks' Gains Erased as Omicron Reveals Itself in U.S.

The major benchmarks swung sharply lower after first U.S. case of the omicron variant of COVID-19 was identified.
December 1, 2021